Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review

IF 4.3 2区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Helicobacter Pub Date : 2024-10-26 DOI:10.1111/hel.13145

{"title":"Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review","authors":"","doi":"10.1111/hel.13145","DOIUrl":null,"url":null,"abstract":"C. Cabrera, J. Torres, C. Serrano, P. Gallardo, V. Orellana, S. George, M. O'Ryan, and Y. Lucero, “Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review,” Helicobacter 29, (2024): e13101. https://doi.org/10.1111/hel.13101.In the article, the errors detailed below were identified. These errors are due to an earlier version of the manuscript being published. These have been corrected in the online version of the article, and they do not affect the overall conclusions.\n Abstract\n The first sentence of the Results paragraph originally stated that out of 51 studies, 45 were excluded. This has been corrected to 44 excluded studies.The second sentence of the Results paragraph originally read, “the quality of the six analyzed studies…was satisfactory.” This has been corrected to seven analyzed studies.The fourth sentence of the Results paragraph originally read, “Clarithromycin resistance ranged from 8.0% to 26.7% (6 studies; 297 samples).” This has been corrected to 8.1%–79.6% (seven studies, 346 samples).\n Results\n In the second paragraph of section 3.1, it was originally stated that 16 studies were excluded and that eight were conducted solely in adult populations. This has been corrected to read that 15 studies were excluded and nine were conducted solely in adult populations.In the first paragraph of section 3.2, it was originally stated that the quality of the six selected studies was assessed. This has been corrected to seven studies. Additionally, it was stated that the other four studies used statistical tools to validate their results. This has been corrected to six studies.In the first paragraph of section 3.3, the first sentence originally read, “All six studies were cross-sectional observational studies, each including pediatric patients [7–12].” This has been corrected to “All seven studies were cross-sectional observational studies, each including pediatric patients [7–13].” Additionally, the fifth sentence originally stated that two of the studies evaluated antimicrobial resistance. This has been corrected to three studies.In the second paragraph of section 3.4, the first sentence originally read, “Genotypic studies (Table 2) explored susceptibility to clarithromycin (n = 3; 139 samples).” This has been corrected to “Genotypic studies explored susceptibility to clarithromycin (n = 4; 188 samples).” Additionally, the second sentence originally read, “The mean rate of resistance to clarithromycin was 13.8%, with the A2143G mutation being the most frequently detected in these strains (87.5%, 14/16 tested), followed by the A2142G mutation (12.5%, 2/16 tested).” This has been corrected to, “The resistance to clarithromycin ranged between 8.1% and 79.6%, with the A2143G mutation as the most frequently detected (38.5%, 15/39 tested), followed by the A2142G mutation (33.3%, 13/39 tested).”\n Discussion\n In the fifth paragraph, it was originally stated that four out of the six included studies reported clarithromycin resistance values. This has been corrected to five out of the seven included studies reported clarithromycin resistance values.In the sixth paragraph, it was originally stated that susceptibility testing for metronidazole was conducted in four out of the six studies. This has been corrected to susceptibility testing for metronidazole was conducted in four out of the seven studies.In the seventh paragraph, it was originally stated that the rate of resistance to amoxicillin was determined in three out of the six studies. This has been corrected to the rate of resistance to amoxicillin was determined in three out of the seven studies.","PeriodicalId":13223,"journal":{"name":"Helicobacter","volume":"29 5","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hel.13145","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Helicobacter","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hel.13145","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

C. Cabrera, J. Torres, C. Serrano, P. Gallardo, V. Orellana, S. George, M. O'Ryan, and Y. Lucero, “Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review,” Helicobacter 29, (2024): e13101. https://doi.org/10.1111/hel.13101.

In the article, the errors detailed below were identified. These errors are due to an earlier version of the manuscript being published. These have been corrected in the online version of the article, and they do not affect the overall conclusions.

Abstract

The first sentence of the Results paragraph originally stated that out of 51 studies, 45 were excluded. This has been corrected to 44 excluded studies.

The second sentence of the Results paragraph originally read, “the quality of the six analyzed studies…was satisfactory.” This has been corrected to seven analyzed studies.

The fourth sentence of the Results paragraph originally read, “Clarithromycin resistance ranged from 8.0% to 26.7% (6 studies; 297 samples).” This has been corrected to 8.1%–79.6% (seven studies, 346 samples).

Results

In the second paragraph of section 3.1, it was originally stated that 16 studies were excluded and that eight were conducted solely in adult populations. This has been corrected to read that 15 studies were excluded and nine were conducted solely in adult populations.

In the first paragraph of section 3.2, it was originally stated that the quality of the six selected studies was assessed. This has been corrected to seven studies. Additionally, it was stated that the other four studies used statistical tools to validate their results. This has been corrected to six studies.

In the first paragraph of section 3.3, the first sentence originally read, “All six studies were cross-sectional observational studies, each including pediatric patients [7–12].” This has been corrected to “All seven studies were cross-sectional observational studies, each including pediatric patients [7–13].” Additionally, the fifth sentence originally stated that two of the studies evaluated antimicrobial resistance. This has been corrected to three studies.

In the second paragraph of section 3.4, the first sentence originally read, “Genotypic studies (Table 2) explored susceptibility to clarithromycin (n = 3; 139 samples).” This has been corrected to “Genotypic studies explored susceptibility to clarithromycin (n = 4; 188 samples).” Additionally, the second sentence originally read, “The mean rate of resistance to clarithromycin was 13.8%, with the A2143G mutation being the most frequently detected in these strains (87.5%, 14/16 tested), followed by the A2142G mutation (12.5%, 2/16 tested).” This has been corrected to, “The resistance to clarithromycin ranged between 8.1% and 79.6%, with the A2143G mutation as the most frequently detected (38.5%, 15/39 tested), followed by the A2142G mutation (33.3%, 13/39 tested).”

Discussion

In the fifth paragraph, it was originally stated that four out of the six included studies reported clarithromycin resistance values. This has been corrected to five out of the seven included studies reported clarithromycin resistance values.

In the sixth paragraph, it was originally stated that susceptibility testing for metronidazole was conducted in four out of the six studies. This has been corrected to susceptibility testing for metronidazole was conducted in four out of the seven studies.

In the seventh paragraph, it was originally stated that the rate of resistance to amoxicillin was determined in three out of the six studies. This has been corrected to the rate of resistance to amoxicillin was determined in three out of the seven studies.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

拉丁美洲儿童和青少年幽门螺杆菌对抗生素耐药性的修正（2008-2023 年）：系统回顾。

C.Cabrera, J. Torres, C. Serrano, P. Gallardo, V. Orellana, S. George, M. O'Ryan, and Y. Lucero, "Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008-2023)：https://doi.org/10.1111/hel.13101.In，发现了以下错误。这些错误是由于较早版本的稿件发表所致。这些错误已在文章的网络版中更正，且不影响总体结论。摘要结果段落的第一句话最初指出，在 51 项研究中，有 45 项被排除在外。结果段第二句原为 "六项分析研究的质量......令人满意"。结果段落第四句原为："克拉霉素耐药率从 8.0% 到 26.7%（6 项研究；297 个样本）"。现更正为 8.1%-79.6%（7 项研究，346 个样本）。结果在第 3.1 节的第二段中，最初指出有 16 项研究被排除在外，其中 8 项研究仅在成人群体中进行。在第 3.2 节的第一段中，最初的说法是对所选的六项研究进行了质量评估。现更正为七项研究。此外，该段还指出其他四项研究使用了统计工具来验证其结果。在第 3.3 节第一段中，第一句原为 "所有六项研究均为横断面观察性研究，每项研究均包括儿科患者[7-12]"。现更正为 "所有七项研究均为横断面观察研究，每项研究均包括儿科患者[7-13]"。此外，第五句最初指出其中两项研究评估了抗菌药耐药性。在第 3.4 节第二段中，第一句原为 "基因型研究（表 2）探讨了对克拉霉素的敏感性（n = 3；139 个样本）"。现已更正为 "基因型研究探讨了对克拉霉素的敏感性（n = 4；188 个样本）"。此外，第二句原为："对克拉霉素的平均耐药率为 13.8%，在这些菌株中最常检测到的是 A2143G 突变（87.5%，14/16 例检测），其次是 A2142G 突变（12.5%，2/16 例检测）"。现更正为："对克拉霉素的耐药性介于 8.1%和 79.6%之间，其中最常检测到的是 A2143G 突变（38.5%，15/39 例检测），其次是 A2142G 突变（33.3%，13/39 例检测）"。讨论在第 5 段中，最初指出所纳入的六项研究中有四项报告了克拉霉素耐药值。在第 6 段中，最初的表述是六项研究中有四项报告了甲硝唑的药敏试验，现更正为七项纳入研究中有五项报告了克拉霉素的耐药值。在第 7 段中，最初的表述是，在 6 项研究中，有 3 项研究确定了对阿莫西林的耐药率。在第 7 段中，原先的表述是在 6 项研究中的 3 项中确定了对阿莫西林的耐药率，现更正为在 7 项研究中的 3 项中确定了对阿莫西林的耐药率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Helicobacter 医学-微生物学

CiteScore

8.40

自引率

9.10%

发文量

审稿时长

2 months

期刊介绍： Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of gastroenterology; microbiology; vaccine development; laboratory animal science.